IRIS
ORDITURA, Michele
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.669
NA - Nord America 6.597
AS - Asia 5.078
SA - Sud America 825
Continente sconosciuto - Info sul continente non disponibili 553
AF - Africa 86
OC - Oceania 13
Totale 25.821
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 7.860
US - Stati Uniti d'America 6.419
SG - Singapore 1.683
IE - Irlanda 1.380
CN - Cina 1.090
HK - Hong Kong 804
IT - Italia 792
BR - Brasile 683
UA - Ucraina 635
VN - Vietnam 601
GB - Regno Unito 511
DE - Germania 500
FR - Francia 349
KR - Corea 334
FI - Finlandia 188
SE - Svezia 151
IN - India 125
GR - Grecia 121
CA - Canada 110
TR - Turchia 106
BD - Bangladesh 85
JP - Giappone 85
AR - Argentina 48
PL - Polonia 36
MX - Messico 35
ID - Indonesia 33
NL - Olanda 33
IQ - Iraq 27
AT - Austria 26
EC - Ecuador 23
ZA - Sudafrica 19
CO - Colombia 17
VE - Venezuela 17
BE - Belgio 16
ES - Italia 16
MA - Marocco 16
SC - Seychelles 13
CL - Cile 12
CZ - Repubblica Ceca 11
PK - Pakistan 11
AL - Albania 9
TN - Tunisia 9
NP - Nepal 8
PE - Perù 8
SA - Arabia Saudita 8
AE - Emirati Arabi Uniti 7
EG - Egitto 7
IL - Israele 7
KE - Kenya 7
NZ - Nuova Zelanda 7
PH - Filippine 7
PY - Paraguay 7
AU - Australia 6
EU - Europa 6
IR - Iran 6
LT - Lituania 6
MY - Malesia 6
TH - Thailandia 6
UZ - Uzbekistan 6
BH - Bahrain 5
BO - Bolivia 5
DO - Repubblica Dominicana 5
HN - Honduras 5
JO - Giordania 5
CR - Costa Rica 4
JM - Giamaica 4
LB - Libano 4
PT - Portogallo 4
SN - Senegal 4
UY - Uruguay 4
CH - Svizzera 3
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
KG - Kirghizistan 3
LU - Lussemburgo 3
AO - Angola 2
AZ - Azerbaigian 2
CG - Congo 2
CY - Cipro 2
DZ - Algeria 2
HU - Ungheria 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
RS - Serbia 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
AG - Antigua e Barbuda 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
GP - Guadalupe 1
GY - Guiana 1
HR - Croazia 1
Totale 25.259
Salva come PNG Salva come JPEG
Città #
Moscow 2.854
Dublin 1.369
Jacksonville 936
San Jose 926
Hong Kong 796
Santa Clara 760
Singapore 682
Chandler 643
Seoul 310
Ashburn 288
Ho Chi Minh City 189
Princeton 188
Medford 171
New York 154
Hanoi 137
Beijing 133
Caserta 129
Bremen 122
Hefei 119
Roxbury 118
Naples 109
Ann Arbor 107
Boardman 103
San Mateo 94
Council Bluffs 88
Bengaluru 87
Munich 85
Wilmington 75
Dallas 64
Los Angeles 63
Woodbridge 61
São Paulo 60
The Dalles 53
Elora 52
Nanjing 49
Des Moines 46
Dong Ket 36
Napoli 36
Milan 35
Cambridge 34
Nuremberg 34
Haiphong 33
Jinan 32
Kraków 29
Da Nang 26
Rio de Janeiro 24
Rome 22
Helsinki 21
Houston 21
Mountain View 21
Toronto 18
Turku 18
Changsha 17
Shanghai 17
Tianjin 17
Amsterdam 15
Brussels 15
Curitiba 15
Norwalk 15
Tokyo 15
Vienna 15
Aiello Del Sabato 14
Atlanta 14
Memphis 14
Nanchang 14
Orem 14
Shenyang 14
Belo Horizonte 13
Hangzhou 13
Biên Hòa 12
Chicago 12
Guangzhou 12
Porto Alegre 12
Brasília 11
Chennai 11
Frankfurt am Main 11
Ottawa 11
Zhengzhou 11
Auburn Hills 10
Aversa 10
Brno 10
Campinas 10
Guarulhos 10
Hải Dương 10
Johannesburg 10
Mexico City 10
Taizhou 10
Thái Bình 10
Thái Nguyên 10
Baghdad 9
Düsseldorf 9
Istanbul 9
Jakarta 9
Montreal 9
Caracas 8
Columbus 8
Dhaka 8
Guayaquil 8
Bogotá 7
Brooklyn 7
Totale 13.215
Salva come PNG Salva come JPEG
Nome #
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 312
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis 211
Anti-epidermal growth factor receptor monoclonal antibodies in cancer therapy. 209
ONCOLOGIA MEDICA 209
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 198
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients 195
Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis 188
Effect of preoperative chemoradiotherapy on outcome of patients with locally advanced esophagogastric junction adenocarcinoma—a pilot study. Curr Oncol 21, 3, june 2014 125-133 188
Adjuvant chemoradiotherapy in patients with stage III-IV radically resected gastric cancer: a pilot study 186
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience 185
A multicenter phase II study of induction chemotherapy with FOLFOX-4 and cetuximab followed by radiation and cetuximab in locally advanced oesophageal cancer 181
Modified versus standard D2 lymphadenectomy in total gastrectomy for nonjunctional gastric carcinoma with lymph node metastasis 179
A possible connective tissue primary lymphoepithelioma-like carcinoma (LELC). 179
Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibitors 178
Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: A propensity score-matched analysis 178
Naples Prognostic Score, Based on Nutritional and Inflammatory Status, is an Independent Predictor of Long-term Outcome in Patients Undergoing Surgery for Colorectal Cancer 176
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) 175
Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience 174
CD 26-positive/CD 326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence 173
Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy 173
Amifostine: a selective cytoprotective agent of normal tissues from chemo-radiotherapy induced toxicity (Review) 172
Clinical management of advanced gastric cancer: Role of new molecular drugs. 170
Antitumor activity of sorafenib in human cancer cell lines with acquired resistance to EGFR and VEGFR tyrosine kinase inhibitors. 168
Elevated perioperative serum vascular endothelial growth factor levels in patients with colon carcinoma. 166
Different Biomarkers address different colorectal cancer stem cell populations: who's the killer? 166
Mixed Neuroendocrine Non-Neuroendocrine Neoplasms of the Gastrointestinal Tract: A Case Series 164
Liquid Biopsy at Home: Delivering Precision Medicine for Patients with Cancer During the Covid-19 Pandemic 164
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer. 163
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment 162
Behavior of circulating CD4+CD25+FOXP3* regulatory T cells in colon cancer patients undergoing surgery 162
Indocyanine Green Fluorescence Imaging-Guided Surgery in Primary and Metastatic Liver Tumors 162
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 162
Pancreatic fistula following pancreatoduodenectomy. Evaluation of different surgical approaches in the management of pancreatic stump. Literature review. 159
Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival 158
A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10 158
Treatment of gastric cancer. 157
Cetuximab, a chimeric human mouse anti-epidermal growth factor receptor monoclonal antibody, in the treatment of human colorectal cancer 155
Conversion chemotherapy followed by epatic resection in colorectal cancer with initially unresectable liver-limited metastases 155
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review. 153
Post-Irradiation Breast Angiosarcoma: All the Possible Treatments and Electrochemotherapy. Case Report and Literature Review 151
Circulating levels of interleukin-10 and interleukin-6 in gastric and colon cancer patients before and after surgery: relationship with radicality and outcome 150
Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. 150
Adult Wilms' tumor: a case report 149
Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer 148
Fluorescence-Guided Surgery in the Combined Treatment of Peritoneal Carcinomatosis from Colorectal Cancer: Preliminary Results and Considerations 148
Neutrophil to lymphocyte ratio is a strong predictor of tumor recurrence in early colon cancers: a propensity score-matched analysis 147
Correlation between efficacy and skin rash occurrence following treatment with the epidermal growth factor receptor inhibitor cetuximab: a single institution retrospective analysis 146
Beyond Platinum, ICIs in Metastatic Cervical Cancer: A Systematic Review 145
Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors 144
Is complete mesocolic excision with central vascular ligation safe and effective in the surgical treatment of right-sided colon cancers ? A prospective study. 144
Addition of either irinotecan or methotrexate to bolus 5-fluorouracil and high-dose folinic acid every 2 weeks in advanced colorectal carcinoma: A randomised study by the Southern Italy Cooperative Oncology Group 143
Three dimensional primary cultures for selecting human breast cancers that are sensitive to the anti-tumor activity of ipatasertib or taselisib in combination with anti-microtubule cytotoxic drugs 142
Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review 141
Preoperative Neutrophil to Lymphocyte Ratio and Lymphocyte to Monocyte Ratio are Prognostic Factors in Gastric Cancers Undergoing Surgery 141
HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study 140
Anthracycline-induced cardiotoxicity: monitoring and prevention of the lesion 140
Farmacogenomica e cancro colorettale 139
Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass 139
Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients 139
Atypycal presentation of Merkel cell carcinoma positive to polyomavirus DNA detection: experience from a single center 138
The over-the-scope-clip (OTSC) system is effective in the treatment of chronic esophago-jejunal anastomotic leakage 138
Triple-Negative Breast Cancers: Systematic Review of the Literature on Molecular and Clinical Features with a Focus on Treatment with Innovative Drugs 137
Complete response to preoperative chemoradiation and survival in esophageal cancer : a pooled analysis of three singe-institution phase II trials. 136
Adjuvant chemotherapy of gastric cancer: which regimen? 135
Serum interleukin-10 is an independent prognostic factor in advanced solid tumors 134
p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate 134
Increased circulating levels of vascular endothelial growth factor C can predict outcome in resectable gastric cancer patients 134
Synergistic Antitumor Activity of Sorafenib in Combination with Epidermal Growth Factor Receptor Inhibitors in Colorectal and Lung Cancer Cells 133
Cardiotossicità da antracicline: attualità e prospettive 132
Immune-Based Therapy in Triple-Negative Breast Cancer: From Molecular Biology to Clinical Practice 131
Implementation of BRCA mutations testing in formalin-fixed paraffin-embedded (FFPE) samples of different cancer types 131
The lymph node ratio is a powerful prognostic factor of node-positive colon cancers undergoing potentially curative surgery. 131
Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies 131
An Integrated In Silico, In Vitro and Tumor Tissues Study Identified Selenoprotein S (SELENOS) and Valosin-Containing Protein (VCP/p97) as Novel Potential Associated Prognostic Biomarkers in Triple Negative Breast Cancer 131
Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report. 130
Elevated serum levels of interleukin-8 in advanced non-small cell lung cancer patients: Relationship with prognosis 130
TRASTUZUMAB RESISTANCE IN BREAST CANCER 130
Propensity score-matched comparison between complete mesocolic excision and classic right hemicolectomy for colon cancer 130
Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions 130
Integrated therapy in localized gastric cancer: targeted and tailored approach. 129
Il linfoma primitivo della parotide: una localizzazione infrequente 129
Pegylated liposomal doxorubicin: pharmacologic and clinical evidence of potent antitumor activity with reduced anthracyclina-induced cardiotoxicity (review) 129
Phosphatidylinositol 3-kinase (PI3Ka)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells 129
Serum vascular endothelial growth factor (VEGF)levels correlate with tumor VEGF and p53 overexpression in endocrine positive primary breast cancer 127
Chemoradiotherapy as adjuvant treatment of gastric cancer 126
Determination of molecular marker expression can predict clinical outcome in colon carcinomas 126
A pilot study of adjuvant chemotherapy with double modulation of 5-fluorouracil by methotrexate and leucovorin in gastric cancer patients. 125
Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation 124
Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery 124
Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator 124
Targeting EGFR in Pancreatic Cancer Treatment. 124
Clinical activity of FOLFIRI plus cetuximab according to extended gene mutation status by next generation sequencing: findings from the CAPRI-GOIM trial. 123
Prognostic significance of circulating IL-10 and IL-6 serum levels in colon cancer patients undergoing surgery 123
Ventricular repolarization time indexes following anthracycline treatment 122
ENDOSONOGRAPHIC ASSESSMENT OF RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN PREDICTING SURVIVAL OF ESOPHAGEAL CARCINOMA PATIENTS 121
Post- operative xelox and chemoradiation in stage III-IV radically resected gastric cancer patients: preliminary results of a pilot study. 121
Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients 120
Capecitabine plus weekly oxaliplatin in gastrointestinal tumors. A phase I study 120
Pancreatic neuroendocrine tumors: Nosography, management and treatment 120
Postoperative detection of circulating tumor cells predicts tumor recurrence in colorectal cancer patients 119
Totale 15.070
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.955
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.955
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.051 0 3 17 19 407 6 19 37 41 53 114 335
2022/20232.666 319 45 37 206 304 205 15 158 1.281 11 44 41
2023/2024993 84 31 48 85 347 127 9 21 8 18 64 151
2024/20253.006 22 92 40 76 476 383 396 275 414 346 233 253
2025/202613.409 484 606 636 678 1.036 7.367 582 766 454 338 215 247
2026/2027415 141 274 0 0 0 0 0 0 0 0 0 0
Totale 25.821